Published on in Vol 5, No 1 (2016): Jan-Mar

Multiple Sclerosis Therapy With Disease-Modifying Treatments in Germany: The PEARL (ProspEctive phArmacoeconomic cohoRt evaluation) Noninterventional Study Protocol

Multiple Sclerosis Therapy With Disease-Modifying Treatments in Germany: The PEARL (ProspEctive phArmacoeconomic cohoRt evaluation) Noninterventional Study Protocol

Multiple Sclerosis Therapy With Disease-Modifying Treatments in Germany: The PEARL (ProspEctive phArmacoeconomic cohoRt evaluation) Noninterventional Study Protocol

Journals

  1. Ziemssen T, Hillert J, Butzkueven H. The importance of collecting structured clinical information on multiple sclerosis. BMC Medicine 2016;14(1) View
  2. D'Amico E, Haase R, Ziemssen T. Review: Patient-reported outcomes in multiple sclerosis care. Multiple Sclerosis and Related Disorders 2019;33:61 View
  3. Schriefer D, Haase R, Ettle B, Ziemssen T. Patient‐ versus physician‐reported relapses in multiple sclerosis: insights from a large observational study. European Journal of Neurology 2020;27(12):2531 View
  4. Ness N, Haase R, Kern R, Schriefer D, Ettle B, Cornelissen C, Akguen K, Ziemssen T. The Multiple Sclerosis Health Resource Utilization Survey (MS-HRS): Development and Validation Study. Journal of Medical Internet Research 2020;22(3):e17921 View
  5. Ness N, Schriefer D, Haase R, Ettle B, Cornelissen C, Ziemssen T. Differentiating societal costs of disability worsening in multiple sclerosis. Journal of Neurology 2020;267(4):1035 View
  6. Alsop J, Medin J, Cornelissen C, Vormfelde S, Ziemssen T, Ramagopalan S. Two studies in one: A propensity-score-matched comparison of fingolimod versus interferons and glatiramer acetate using real-world data from the independent German studies, PANGAEA and PEARL. PLOS ONE 2017;12(5):e0173353 View
  7. Ness N, Schriefer D, Haase R, Ettle B, Ziemssen T. Real-World Evidence on the Societal Economic Relapse Costs in Patients with Multiple Sclerosis. PharmacoEconomics 2020;38(8):883 View
  8. Haase R, Schriefer D, Ziemssen T. Der Patient als Experte. DNP - Der Neurologe & Psychiater 2020;21(5):33 View
  9. Schriefer D, Ness N, Haase R, Ziemssen T. Gender disparities in health resource utilization in patients with relapsing–remitting multiple sclerosis: a prospective longitudinal real-world study with more than 2000 patients. Therapeutic Advances in Neurological Disorders 2020;13:175628642096027 View
  10. Ness N, Schriefer D, Haase R, Ziemssen T. Der Multiple Sclerosis Health Resource Utilization Survey. Fortschritte der Neurologie · Psychiatrie 2022;90(01/02):42 View